Results
499
Mid-Large Cap Stocks
499 companies
Concord Biotech
Market Cap: ₹160.3b
A biopharma company, engages in the research and development, manufacturing, marketing, and sale of pharmaceutical products in India and internationally.
CONCORDBIO
₹1,532.10
7D
0.4%
1Y
5.0%
GSK
Market Cap: UK£58.0b
Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
GSK
UK£14.29
7D
4.8%
1Y
-19.7%
Genus
Market Cap: UK£1.4b
Operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia.
GNS
UK£19.98
7D
-3.2%
1Y
9.2%
Genomma Lab Internacional. de
Market Cap: Mex$20.5b
Provides pharmaceutical and personal care products primarily in Mexico and internationally.
LAB B
Mex$21.01
7D
-1.6%
1Y
23.2%
Qiagen
Market Cap: US$9.2b
Provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally.
QGEN
US$42.32
7D
0.2%
1Y
-4.7%
Société de Therapeutique Marocaine
Market Cap: د.م10.1b
A pharmaceutical company, engages in the manufacturing and sale of medicines in Morocco.
SOT
د.م1,444.00
7D
-1.1%
1Y
45.7%
Hypera
Market Cap: R$15.0b
Operates as a pharmaceutical company in Brazil.
HYPE3
R$23.72
7D
-3.9%
1Y
-21.2%
Shenzhen Kangtai Biological Products
Market Cap: CN¥15.6b
Shenzhen Kangtai Biological Products Co., Ltd.
300601
CN¥13.99
7D
-0.4%
1Y
-26.1%
Jiuzhitang
Market Cap: CN¥7.5b
Provides traditional Chinese, chemical, biological, and health medicine products in China.
000989
CN¥8.84
7D
-3.4%
1Y
15.1%
Sunflower Pharmaceutical GroupLtd
Market Cap: CN¥9.3b
Engages in the research and development, manufacturing, and marketing of Chinese patent medicines in China and internationally.
002737
CN¥15.92
7D
-1.1%
1Y
-44.6%
Sino Biopharmaceutical
Market Cap: HK$75.3b
An investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China.
1177
HK$4.21
7D
7.9%
1Y
43.7%
China Resources Boya Bio-pharmaceutical GroupLtd
Market Cap: CN¥13.5b
Engages in the blood product businesses in China.
300294
CN¥26.72
7D
-0.04%
1Y
-18.1%
Daiichi Sankyo Company
Market Cap: JP¥7.0t
Manufactures and sells pharmaceutical products in Japan, North America, Europe, and internationally.
4568
JP¥3,753.00
7D
11.7%
1Y
-30.2%
Jubilant Pharmova
Market Cap: ₹169.2b
Operates as an integrated pharmaceutical company in India, the Americas, Europe, and internationally.
530019
₹1,068.65
7D
18.0%
1Y
48.9%
Chugai Pharmaceutical
Market Cap: JP¥12.4t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥7,516.00
7D
0.01%
1Y
57.0%
Bachem Holding
Market Cap: CHF 3.9b
Provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide.
BANB
CHF 49.50
7D
-6.5%
1Y
-42.9%
Shandong Xinhua Pharmaceutical
Market Cap: HK$9.4b
Develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People’s Republic of China, the Americas, Europe, and internationally.
719
HK$5.91
7D
3.7%
1Y
5.5%
Yifan Pharmaceutical
Market Cap: CN¥15.2b
Engages in the researches and develops, produces, and sells macromolecules, biosimilars, generic drugs, small molecules, synthetic biologics, and special traditional Chinese medicines in China Southeast Asia, Europe, North America, Singapore, South Korea, Italy, Germany, and the United States, and internationally.
002019
CN¥12.47
7D
3.0%
1Y
-7.4%
Tianjin Chase Sun PharmaceuticalLtd
Market Cap: CN¥11.1b
Engages in the research and development, production, and sale of various pharmaceutical products in China and internationally.
300026
CN¥3.71
7D
8.8%
1Y
2.2%
Shanghai Fosun Pharmaceutical (Group)
Market Cap: CN¥57.6b
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
600196
CN¥23.95
7D
0.8%
1Y
3.2%
Towa Pharmaceutical
Market Cap: JP¥145.1b
Researches, develops, produces, and sells ethical drugs, active pharmaceutical ingredients, and intermediates in Japan.
4553
JP¥2,947.00
7D
20.0%
1Y
4.6%
Alembic Pharmaceuticals
Market Cap: ₹190.9b
Develops, manufactures, and markets pharmaceutical products in India and internationally.
APLLTD
₹971.20
7D
6.2%
1Y
1.1%
Agilent Technologies
Market Cap: US$31.1b
Provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.
A
US$109.68
7D
-2.4%
1Y
-27.1%
Eli Lilly
Market Cap: US$670.6b
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally.
LLY
US$724.95
7D
1.3%
1Y
-9.7%
Shanghai RAAS Blood Products
Market Cap: CN¥45.2b
Engages in the manufacture and sale of blood products in China.
002252
CN¥6.85
7D
1.3%
1Y
-2.6%
SSY Group
Market Cap: HK$8.6b
An investment holding company, research, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally.
2005
HK$2.91
7D
0.7%
1Y
-38.5%
Hubei Jumpcan Pharmaceutical
Market Cap: CN¥25.2b
Engages in the research, development, manufacturing, and trading of Chinese traditional medicines, western medicines, daily use chemical based Chinese traditional medicines, and Chinese medicine health products in China.
600566
CN¥27.32
7D
2.1%
1Y
-27.0%
CSPC Pharmaceutical Group
Market Cap: HK$74.1b
An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.
1093
HK$6.48
7D
13.5%
1Y
0.6%
Tonghua Dongbao Pharmaceutical
Market Cap: CN¥14.8b
Researches and develops, manufactures, and sells pharmaceutical for the treatment of diabetes, endocrine, and cardiovascular and cerebrovascular diseases products in China.
600867
CN¥7.64
7D
0.5%
1Y
-20.3%
Beijing Aosaikang Pharmaceutical
Market Cap: CN¥15.8b
Beijing Aosaikang Pharmaceutical Co., Ltd.
002755
CN¥17.03
7D
-1.9%
1Y
62.8%
Dong-E-E-JiaoLtd
Market Cap: CN¥36.2b
Research and development, production, and sale of Ejiao and a series of Chinese patent medicines, health foods, and foods.
000423
CN¥56.36
7D
0.7%
1Y
-18.0%
Cosmo Pharmaceuticals
Market Cap: CHF 869.6m
Focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.
COPN
CHF 53.90
7D
3.3%
1Y
-25.9%
Jiang Zhong PharmaceuticalLtd
Market Cap: CN¥14.5b
Engages in the research and development, production, and sale of Chinese patent medicines and health foods in Mainland China.
600750
CN¥23.22
7D
0.4%
1Y
-10.4%
Yantai Dongcheng Pharmaceutical GroupLtd
Market Cap: CN¥11.9b
Engages in the manufacture and sale of biochemical APIs, finished dosage forms, nuclide drugs, and healthy products for cardiovascular, antitumor, urology, orthopedics, and other therapeutic areas.
002675
CN¥14.45
7D
-0.4%
1Y
9.1%
Tibet Cheezheng Tibetan Medicine
Market Cap: CN¥12.9b
Tibet Cheezheng Tibetan Medicine Co., Ltd.
002287
CN¥24.35
7D
-2.2%
1Y
13.6%
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi
Market Cap: ₺41.7b
A pharmaceutical company, manufactures and supplies products to treat rare diseases and disorders worldwide.
GENIL
₺136.20
7D
-0.9%
1Y
118.8%